Biblio

[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is O  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Das R, Le D, Kan H-M, Le TT, Park JY, Nguyen TD, Lo KW-H. Osteo-inductive effect of piezoelectric stimulation from the poly(l-lactic acid) scaffolds. PLoS One. 2024;19(2):e0299579.
David KA, Sundaram S, Kim S-H, Vaca R, Lin Y, Singer S, Malecek M-K, Carter J, Zayac A, Kim MSun, et al. Older Patients with Primary Central Nervous System Lymphoma: Survival and Prognostication Across 20 US Cancer Centers. Am J Hematol. 2023.
Davidson JR, Lee DRae, Suresh D, Child HWright Rn, Upadhyaya M, Yardley IE. Open Primary Button vs. Laparoscopic Percutaneous Endoscopic Gastrostomy: Results From a Case-Control Study. J Pediatr Gastroenterol Nutr. 2020.
de Araújo RLins Fuent, Lyko Kde Fátima, Funke VAraújo Mo, Torres-Pereira CCarvalho. Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease. Rev Bras Hematol Hemoter. 2014;36(1):65-8.
DE Berti M, Goupille C, Doucet M, Arbion F, Vilde A, Body G, Ouldamer L. Oncological Safety of Autologous Fat Grafting in Breast Reconstruction after Mastectomy for cancer: a case-control study. J Gynecol Obstet Hum Reprod. 2021:102257.
De Carlo F, Witte TR, W Hardman E, Claudio PPaolo. Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to Chemotherapy. PLoS One. 2013;8(7):e69760.
de Latour RPeffault, Röth A, Kulasekararaj AG, Han B, Scheinberg P, Maciejewski JP, Ueda Y, de Castro CM, Di Bona E, Fu R, et al. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2024;390(11):994-1008.
de Leeuw DC, Ossenkoppele GJ, Janssen JJWM. Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment. Curr Oncol Rep. 2022.
de Oliveira LFelipe, Filho DMendes, Marques BLemes, Maciel GFigueiredo, Parreira RCambraia, Neto JRodrigues, Da Silva PElias Ferr, Guerra ROliveira, da Silva MVinicius, Santiago Hda Costa, et al. Organoids as a novel tool in modelling infectious diseases. Semin Cell Dev Biol. 2022.
de Pagter APJ, Bredius RGM, Kuijpers TW, Tramper J, van der Burg M, van Montfrans J, Driessen GJ. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening. Eur J Pediatr. 2015.
Dedoni S, Scherma M, Camoglio C, Siddi C, Dazzi L, Puliga R, Frau J, Cocco E, Fadda P. An overall view of the most common experimental models for multiple sclerosis. Neurobiol Dis. 2023:106230.
Deepak K, Roy PKumar, Kola P, Mukherjee B, Mandal M. An overview of kinin mediated events in cancer progression and therapeutic applications. Biochim Biophys Acta Rev Cancer. 2022:188807.
Dehghan S, Aref E, Raoufy MReza, Javan M. An Optimized Animal Model of Lysolecithin Induced Demyelination in Optic Nerve; More Feasible, More Reproducible, Promising for Studying the Progressive forms of Multiple Sclerosis. J Neurosci Methods. 2021:109088.
Del Gobbo A, Vaira V, Rocco EGuerini, Palleschi A, Bulfamante G, Ricca D, Fiori S, Bosari S, Ferrero S. The Oncofetal Protein IMP3: A Useful Marker to Predict Poor Clinical Outcome in Neuroendocrine Tumors of the Lung. J Thorac Oncol. 2014.
Dellambra E. Oncogenic ras: A double-edged sword for human epidermal stem and transient amplifying cells. Small GTPases. 2016.
Deng X, Zhang P, Liang T, Deng S, Chen X, Zhu L. Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPARγ and NF-κB pathways. Int J Mol Med. 2015.
Desai R, Huang L, Gonzalez RS, Muthuswamy SK. Oncogenic GNAS uses PKA-dependent and independent mechanisms to induce cell proliferation in human pancreatic ductal and acinar organoids. Mol Cancer Res. 2023.
Desai AV, Gilman AL, Ozkaynak MFevzi, Naranjo A, London WB, Tenney SC, Diccianni M, Hank JA, Parisi MT, Shulkin BL, et al. Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. J Clin Oncol. 2022:JCO2102478.
Desai SH, Spinner MA, Evens AM, Sýkorová A, Bachanova V, Goyal G, Kahl BS, Dorritie KA, Azzi J, Kenkre VP, et al. Overall survival of cHL patients who progress after autologous stem cell transplant: results in novel agent era. Blood Adv. 2023.
Desikan SPrasad, Senapati J, Jabbour E, Abuasab T, Short N, Tang G, Wang S, Kebriaei P, Kadia T, Borthakur G, et al. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. Am J Hematol. 2023.
Deveale B, Brokhman I, Mohseni P, Babak T, Yoon C, Lin A, Onishi K, Tomilin A, Pevny L, Zandstra PW, et al. Oct4 is required ∼e7.5 for proliferation in the primitive streak. PLoS Genet. 2013;9(11):e1003957.
Devoucoux M, Fort V, Khelifi G, Xu J, Alerasool N, Galloy M, Wong N, Bourriquen G, Fradet-Turcotte A, Taipale M, et al. Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes. Cell Rep. 2022;39(11):110947.
Dhamodaran K, Subramani M, Ponnalagu M, Shetty R, Das D. Ocular stem cells: a status update!. Stem Cell Res Ther. 2014;5(2):56.
Dhillon MS, Behera P, Patel S, Shetty V. Orthobiologics and platelet rich plasma. Indian J Orthop. 2014;48(1):1-9.
Dhiman N, Kingshott P, Sumer H, Sharma CS, Rath SNarayan. On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy. Biosens Bioelectron. 2019;137:236-254.

Pages